Nationwide Fund Advisors - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2017$323,000
+18.8%
95,229
-13.4%
0.00%0.0%
Q2 2017$272,000
+14.3%
109,961
+4.7%
0.00%0.0%
Q1 2017$238,000
+1.7%
105,061
-4.9%
0.00%0.0%
Q4 2016$234,000
-35.9%
110,490
+1.4%
0.00%
-50.0%
Q3 2016$365,000
+6.7%
108,9530.0%0.00%
+100.0%
Q2 2016$342,000
-3.4%
108,953
+2.6%
0.00%
-50.0%
Q1 2016$354,000
-8.8%
106,240
-3.0%
0.00%0.0%
Q4 2015$388,000
-72.8%
109,540
-61.4%
0.00%
-66.7%
Q3 2015$1,428,000
-11.0%
283,833
+13.7%
0.01%
-14.3%
Q2 2015$1,604,000
-12.6%
249,533
-4.3%
0.01%0.0%
Q1 2015$1,835,000
-10.5%
260,848
-1.9%
0.01%
-22.2%
Q4 2014$2,050,000
+2.7%
265,864
-0.5%
0.01%
+12.5%
Q3 2014$1,996,000
-20.8%
267,242
+2.6%
0.01%
-20.0%
Q2 2014$2,521,000
+5.5%
260,466
-9.4%
0.01%
-9.1%
Q1 2014$2,390,000
+160.3%
287,618
+164.5%
0.01%
+175.0%
Q4 2013$918,000
+3.0%
108,757
-2.7%
0.00%0.0%
Q3 2013$891,000
+8.4%
111,820
+5.0%
0.00%0.0%
Q2 2013$822,000106,4610.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2014
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders